This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Olanzapine-Induced Manic-Like Syndrome

Jean-Pierre Lindenmayer and Roman Klebanov

Published: June 15, 1998

Article Abstract

Sir: Olanzapine is a new atypical antipsychotic with antidopaminergic and antiserotonergic blocking activity that results in antipsychotic efficacy with an extrapyramidal side effect profile superior to that of conventional neuroleptics. This beneficial side effect profile may make olanzapine particularly suitable for schizophrenic patients who have developed HIV infection. We report 2 HIV-positive chronic schizophrenic patients in whom olanzapine was used and who developed a manic-like psychomotor activation syndrome.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 59

Quick Links: